Radiation oncology residents and practitioners, as well as other health professionals involved in the care of head/neck cancer patients, confront an area of oncology that is widely acknowledged as perhaps the most challenging in the field.

This Head & Neck Cancer session will highlight findings from the 2018 Annual Meeting of ASTRO, focusing on the educational and scientific sessions.

This session highlights recent studies exploring the value of preoperative chemoradiation therapy in borderline resectable pancreatic cancer patients, the role of a radiation boost in rectal cancer, the role of chemoradiation therapy in gastric cancers treated preoperatively or postoperatively, t

The care of patients with metastatic cancers is a substantial component of care in radiation oncology settings.  Palliative care in radiation oncology has often been a neglected area of clinical research.

Improving systemic therapies for metastatic disease have led to an increasing incidence of brain metastasis for patients with solid malignancies.

Adolescents and young adults are a growing population of patients with cancer who face unique developmental and logistical challenges in receiving oncologic care.

The session will go through the published guidelines providing examples and detailed explanations.

In this session, we will discuss common Head and Neck cancer presentations treated with definitive/post operative radiation. We will discuss coverage of specific nodal volumes based on evidence and published guidelines.

Panel moderators will provide a clinical overview with cases to frame the session.

The speakers are experts in prostate imaging and will:

The definition of the clinical target volume (CTV) is becoming the weakest link in the radiotherapy chain. In this session we will first review some of the challenges of the standard CTV definition process (the "art").